Elos Medtech – subscription of warrants

The management and key employees within the Elos Medtech Group has signed a total of 251,500 warrants in the incentive program 2016/2019 that the Annual General Meeting decided on in April, 2016.

At the Annual General Meeting of Elos Medtech AB, April 26 2016, it was decided to implement an incentive program whereby a maximum of 318,473 warrants can be transferred to senior executives and key employees within the Elos Medtech Group. A total of 251,500 warrants were subscribed, of which 63,000 warrants were signed by CEO Jan Wahlström.

In accordance with the AGM's decision, the subscription price upon exercise of the warrants was set at SEK 147 per share. This is equivalent to 150 percent of the volume-weighted average closing price of the Company share on the NASDAQ Stockholm, during the period of 10 trading days following the date of the Annual General Meeting April 26 2016. The price of the warrants has been calculated at market value using the Black & Scholes model and amounted to 5.67 SEK/warrant. Subscription of shares shall take place between October 1 and December 31, 2019.

If all the Group’s now 318,473 outstanding warrants are exercised, the total dilution amounts to about 5% and 2% of the votes in the Company.

Lidköping, October 28, 2016

Elos Medtech AB (publ)

For further information, please contact: Christian Bergaust, CFO, +46 70 293 50 40, christian.bergaust@elosmedtech.com

This information is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on October 28, 2016, at 17:00 (CET).

For additional information about the Elos Medtech Group, visit www.elosmedtech.com 

Tags:

About Us

Elos Medtech is one of Europe's leading development and production partners for medical technology products and components, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and USA. Customers are mainly internationally active medical technology companies in the market segments Dental Implant Systems, Diagnostics, Medical Devices and Trauma & Spine. Elos Medtech employs more than 500 people worldwide and generates revenue that exceeds MSEK 550. Elos Medtech has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.